FunPep Company Limited
FunPep Company Limited (4881.T) Company Profile & Overview
Explore FunPep Company Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
FunPep Company Limited (4881.T) Company Profile & Overview
FunPep Company Limited engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices based on functional peptides. The company is developing SR-0379, a functional peptide for skin ulcer; FPP003, an antibody-inducing peptide that is in Phase II clinical study for the treatment of psoriasis in Australia, as well as phase II clinical trial for ankylosing spondylitis in Japan; and FPP004X, an antibody-inducing peptide for pollinosis. It is also developing FPP006, a corona peptide vaccine; and FPP005, a antibody including peptide for psoriasis. FunPep Company Limited was incorporated in 2013 and is based in Tokyo, Japan.